---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-025876"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2022-11-30T23:59:59+00:00"
generated_at: "2026-06-21T11:36:49.074870+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Arcadia Biosciences appoints Thomas Schaefer as CFO, succeeding Pamela Haley

## Summary
- Pamela Haley resigns as CFO effective January 3, 2023; will stay in advisory role.
- Thomas J. Schaefer, current VP of Finance and IR, promoted to CFO effective same date.
- Schaefer has 20+ years finance experience, previously at Flavor Producers and Edward Jones, holds CFA.
- Schaefer led commercial launch of GoodWheat and development of long-term strategy Project Greenfield.

## SEC filing metadata
- accession: 0000950170-22-025876
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2022-11-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017022025876/0000950170-22-025876-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017022025876/rkda-20221128.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-025876
- JSON: https://secwatch.observer/filing/0000950170-22-025876.json
- Plain text: https://secwatch.observer/filing/0000950170-22-025876.txt

## Key facts
- Executive change
  Pamela Haley resigned as chief financial officer at Arcadia Biosciences, Inc..
  - Action: resigned
  - Role: chief financial officer
  source text: On November 28, 2022, Pamela Haley provided notice to Arcadia Biosciences, Inc. (“Arcadia”) of her resignation as Arcadia’s chief financial officer, effective as of January 3, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1469443/000095017022025876/0000950170-22-025876-index.htm
- Executive change
  Thomas J. Schaefer was appointed as chief financial officer at Arcadia Biosciences, Inc..
  - Action: appointed
  - Role: chief financial officer
  source text: On November 30, 2022 and effective January 3, 2022, Arcadia’s board of directors appointed Thomas J. Schaefer as Arcadia’s new chief financial officer to succeed Ms. Haley.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1469443/000095017022025876/0000950170-22-025876-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.